Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's Disease

Journal of Neurochemistry

Volumn 50, Issue 6, 1988, Pages 1914-1923

  Araujo, D M ^a   Lapchak, P A ^a   Robitaille, Y ^b,c   Gauthier, S ^a   Quirion, R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Muscarinic receptors; Nicotinic receptors; N Methylcarbamylcholine

Indexed keywords

CHOLINE ACETYLTRANSFERASE; METHYLCARBACHOL; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PIRENZEPINE; RADIOISOTOPE;

AGE; ALZHEIMER DISEASE; BRAIN; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; FEMALE; HUMAN CELL; MALE; NORMAL HUMAN;

ACETYLCHOLINE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBRAL CORTEX; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; MALE; MIDDLE AGE; PIRENZEPINE; RECEPTORS, CHOLINERGIC; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SUBSTANTIA INNOMINATA; SUPPORT, NON-U.S. GOV'T; THALAMUS;

EID: 0023943181     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1988.tb02497.x     Document Type: Article

References (52)

1. 3H]Methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors
2. N‐Methylcarbamyl choline, a novel nicotinic agonist, enhances acetylcholine release from rat brain slices. (Abstr)
3. The effects of nicotine on brain neurotransmitter systems
4. The cholinergic hypothesis of geriatric memory dysfunction
5. Behavioral and biochemical effects of nucleus basalis magnocellularis lesions: implications and possible relevance to understanding or treating Alzheimer's disease
6. 3H]Oxotremorine‐M binding to membranes prepared from rat brain and heart: evidence for subtypes of muscarinic receptors
7. 3H]N‐Methyl‐carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain
8. Identification of a family of muscarinic acetylcholine receptor genes
9. Neurotransmitter‐related enzymes and indices of hypoxia in senile dementia and other abiotrophies
10. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease
11. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease
12. 125I]‐α‐bungarotoxin
13. Studies on the neuro‐transmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer type
14. Neurotransmitter‐related enzymes in senile dementia of the Alzheimer type
15. Postmortem stability of alpha‐bungarotoxin binding sites in mouse and human brain
16. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease
17. 3H]‐nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal
18. Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities
19. Alterations in L‐glutamate binding in Alzheimer's and Huntington's diseases
20. Transmitter deficits in Alzheimer's disease
21. Studies on neurotransmitter binding in senile dementia
22. 3H‐ACh) binding to M‐2 muscarinic receptors in brain and peripheral tissues. (Abstr)
23. 3H]acetylcholine to muscarinic cholinergic receptors
24. Relations between choline acetyltransferase and muscarinic binding in aging and Alzheimer's disease
25. Protein measurement with the Folin phenol reagent
26. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation
27. Aging, Alzheimer's disease, and the cholinergic system
28. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains
29. Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type
30. Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia
31. Mapping of subtypes of muscarinic receptors in the human brain with receptor autoradiographic techniques
32. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
33. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
34. 2 receptors: ligands, autoradiography and functions
35. Comparative localization of pre‐ and postsynaptic markers of muscarinic cholinergic nerve terminals in rat brain
36. 3H]acetylcholine receptors in rat brain: comparison with antagonists
37. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type
38. Human brain receptor autoradiography using whole hemisphere sections. A general method that minimizes tissue artefacts
39. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease
40. Pre‐ and postsynaptic neurochemical alterations in Alzheimer's disease
41. Brain muscarinic receptors in senile dementia
42. 3H]acetylcholine release from mouse cerebral cortical synaptosomes
43. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer‐type dementia
44. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections
45. Choline acetyltransferase
46. 2 muscarinic receptors by guanine nucleotides in rat cerebral cortical and cardiac membranes
47. 2 receptor alterations in the cerebral cortex of patients with senile dementia of the Alzheimer's type (SDAT)
48. Subclassification of muscarinic receptors based upon the selective antagonist pirenzepine
49. An in vitro receptor autoradiographic study of muscarinic cholinergic receptor subtypes in the amygdala and neocortex of patients with Alzheimer's disease
50. Nicotinic acetylcholine binding sites in Alzheimer's disease
51. 3H]‐methylcarbamylcholine, a novel radioligand